Form 4 for MCRB Seres Therapeutics, Inc.
Accepted 2022-07-06 00:00:00 ET · period of report 2022-07-05 · accession 0000899243-22-025516 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-06 | 2022-07-05 | MCRB | Arkowitz David | CFO | A - Grant | $3.15 | +63.5K | 65.5K | +3,175% | +$200.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2022-07-05 | A | A | 63,492 | $3.15 | 65,492 | D | — | — |